• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液代谢组中的小分子影响超氧化物歧化酶 1 的聚集。

Small molecules present in the cerebrospinal fluid metabolome influence superoxide dismutase 1 aggregation.

机构信息

Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Av. da República, EAN, Oeiras 2784-505, Portugal.

出版信息

Int J Mol Sci. 2013 Sep 17;14(9):19128-45. doi: 10.3390/ijms140919128.

DOI:10.3390/ijms140919128
PMID:24048249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3794824/
Abstract

Superoxide dismutase 1 (SOD1) aggregation is one of the pathological markers of amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder. The underlying molecular grounds of SOD1 pathologic aggregation remains obscure as mutations alone are not exclusively the cause for the formation of protein inclusions. Thus, other components in the cell environment likely play a key role in triggering SOD1 toxic aggregation in ALS. Recently, it was found that ALS patients present a specific altered metabolomic profile in the cerebrospinal fluid (CSF) where SOD1 is also present and potentially interacts with metabolites. Here we have investigated how some of these small molecules affect apoSOD1 structure and aggregation propensity. Our results show that as co-solvents, the tested small molecules do not affect apoSOD1 thermal stability but do influence its tertiary interactions and dynamics, as evidenced by combined biophysical analysis and proteolytic susceptibility. Moreover, these compounds influence apoSOD1 aggregation, decreasing nucleation time and promoting the formation of larger and less soluble aggregates, and in some cases polymeric assemblies apparently composed by spherical species resembling the soluble native protein. We conclude that some components of the ALS metabolome that shape the chemical environment in the CSF may influence apoSOD1 conformers and aggregation.

摘要

超氧化物歧化酶 1(SOD1)聚集是肌萎缩侧索硬化症(ALS)的一种病理标志物,这是一种致命的神经退行性疾病。尽管突变并不是导致蛋白质包涵体形成的唯一原因,但 SOD1 病理性聚集的潜在分子基础仍然不清楚。因此,细胞环境中的其他成分可能在 ALS 中触发 SOD1 毒性聚集中发挥关键作用。最近发现,ALS 患者的脑脊液(CSF)中存在特定的代谢组学改变,SOD1 也存在于 CSF 中,并可能与代谢物相互作用。在这里,我们研究了这些小分子中的一些如何影响apoSOD1 的结构和聚集倾向。我们的结果表明,作为共溶剂,测试的小分子不会影响 apoSOD1 的热稳定性,但会影响其三级相互作用和动力学,这可以通过结合生物物理分析和蛋白水解敏感性来证明。此外,这些化合物影响 apoSOD1 的聚集,减少成核时间并促进形成更大且更不溶的聚集体,在某些情况下,聚合体显然由类似可溶性天然蛋白的球形物质组成。我们得出结论,ALS 代谢组的一些成分塑造了 CSF 中的化学环境,可能会影响 apoSOD1 构象和聚集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/ec3a92693cc0/ijms-14-19128f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/6edcd7ffecaf/ijms-14-19128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/4bcdddbc71f2/ijms-14-19128f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/c30411bdce77/ijms-14-19128f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/37e7a1010452/ijms-14-19128f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/41146851327c/ijms-14-19128f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/ec3a92693cc0/ijms-14-19128f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/6edcd7ffecaf/ijms-14-19128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/4bcdddbc71f2/ijms-14-19128f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/c30411bdce77/ijms-14-19128f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/37e7a1010452/ijms-14-19128f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/41146851327c/ijms-14-19128f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c237/3794824/ec3a92693cc0/ijms-14-19128f6.jpg

相似文献

1
Small molecules present in the cerebrospinal fluid metabolome influence superoxide dismutase 1 aggregation.脑脊液代谢组中的小分子影响超氧化物歧化酶 1 的聚集。
Int J Mol Sci. 2013 Sep 17;14(9):19128-45. doi: 10.3390/ijms140919128.
2
Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)?钙离子促进超氧化物歧化酶 1(SOD1)聚集成非纤维状淀粉样蛋白:与肌萎缩侧索硬化症(ALS)中钙超载的毒性作用有关?
J Biol Chem. 2013 Aug 30;288(35):25219-25228. doi: 10.1074/jbc.M113.470740. Epub 2013 Jul 16.
3
Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS.GC/TOFMS 检测肌萎缩侧索硬化症脑脊液代谢组学的疾病相关变化。
PLoS One. 2011 Apr 4;6(4):e17947. doi: 10.1371/journal.pone.0017947.
4
ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.肌萎缩侧索硬化症(ALS)患者的 SOD1 基因突变与无突变的 ALS 患者的脑脊液代谢组学特征不同。
Mol Genet Metab. 2012 Mar;105(3):472-8. doi: 10.1016/j.ymgme.2011.11.201. Epub 2011 Dec 10.
5
Calcium binding to gatekeeper residues flanking aggregation-prone segments underlies non-fibrillar amyloid traits in superoxide dismutase 1 (SOD1).钙与超氧化物歧化酶1(SOD1)中易于聚集的片段两侧的守门残基结合是无纤维淀粉样特性的基础。
Biochim Biophys Acta. 2015 Feb;1854(2):118-26. doi: 10.1016/j.bbapap.2014.11.005. Epub 2014 Nov 25.
6
SOD1 aggregation and ALS: role of metallation states and disulfide status.SOD1 聚集与 ALS:金属化状态和二硫化物状态的作用。
Curr Top Med Chem. 2012;12(22):2560-72. doi: 10.2174/1568026611212220010.
7
Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS.不成熟的超氧化物歧化酶稳定性降低和可溶性聚集体形成增加不能解释 ALS 疾病的严重程度。
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2210-5. doi: 10.1073/pnas.0913021108. Epub 2011 Jan 21.
8
Polyanion binding accelerates the formation of stable and low-toxic aggregates of ALS-linked SOD1 mutant A4V.聚阴离子结合加速了与肌萎缩侧索硬化症相关的超氧化物歧化酶1(SOD1)突变体A4V稳定且低毒聚集体的形成。
Proteins. 2014 Dec;82(12):3356-72. doi: 10.1002/prot.24691. Epub 2014 Oct 1.
9
Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者脑脊液中铜/锌超氧化物歧化酶(SOD1)水平的性别差异。
Amyotroph Lateral Scler. 2008 Jun;9(3):184-7. doi: 10.1080/17482960801984358.
10
Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants.超氧化物歧化酶1(SOD1)衍生肽抑制家族性肌萎缩侧索硬化症SOD1突变体的淀粉样聚集。
ACS Chem Neurosci. 2016 Nov 16;7(11):1595-1606. doi: 10.1021/acschemneuro.6b00227. Epub 2016 Sep 2.

引用本文的文献

1
"Proteinjury": a universal pathological mechanism mediated by cerebrospinal fluid in neurodegeneration and trauma.“蛋白质损伤”:一种由脑脊液介导的、在神经退行性变和创伤中普遍存在的病理机制。
Front Cell Dev Biol. 2025 May 20;13:1593122. doi: 10.3389/fcell.2025.1593122. eCollection 2025.
2
Probing the kinetic stabilities of Friedreich's ataxia clinical variants using a solid phase GroEL chaperonin capture platform.使用固相GroEL伴侣蛋白捕获平台探究弗里德赖希共济失调临床变体的动力学稳定性。
Biomolecules. 2014 Oct 20;4(4):956-79. doi: 10.3390/biom4040956.

本文引用的文献

1
Calcium ions promote superoxide dismutase 1 (SOD1) aggregation into non-fibrillar amyloid: a link to toxic effects of calcium overload in amyotrophic lateral sclerosis (ALS)?钙离子促进超氧化物歧化酶 1(SOD1)聚集成非纤维状淀粉样蛋白:与肌萎缩侧索硬化症(ALS)中钙超载的毒性作用有关?
J Biol Chem. 2013 Aug 30;288(35):25219-25228. doi: 10.1074/jbc.M113.470740. Epub 2013 Jul 16.
2
Structural similarity of wild-type and ALS-mutant superoxide dismutase-1 fibrils using limited proteolysis and atomic force microscopy.利用有限蛋白水解和原子力显微镜研究野生型和 ALS 突变型超氧化物歧化酶-1 纤维的结构相似性。
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10934-9. doi: 10.1073/pnas.1309613110. Epub 2013 Jun 18.
3
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS).
近年来,在发现治疗肌萎缩侧索硬化症(ALS)的小分子方面取得了进展。
Beilstein J Org Chem. 2013 Apr 15;9:717-32. doi: 10.3762/bjoc.9.82. Print 2013.
4
Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.增强线粒体钙缓冲能力可减少错误折叠的 SOD1 聚集和运动神经元死亡,但不能延长遗传性肌萎缩侧索硬化症小鼠模型的生存期。
J Neurosci. 2013 Mar 13;33(11):4657-71. doi: 10.1523/JNEUROSCI.1119-12.2013.
5
Cofactors and metabolites as protein folding helpers in metabolic diseases.代谢疾病中作为蛋白质折叠辅助因子的辅因子和代谢物。
Curr Top Med Chem. 2012;12(22):2546-59. doi: 10.2174/1568026611212220009.
6
Protein misfolding in disease and small molecule therapies.蛋白质错误折叠与疾病及小分子治疗
Curr Top Med Chem. 2012;12(22):2460-9. doi: 10.2174/1568026611212220002.
7
Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype.细胞外聚集的 Cu/Zn 超氧化物歧化酶激活小胶质细胞产生细胞毒性表型。
Glia. 2013 Mar;61(3):409-19. doi: 10.1002/glia.22444. Epub 2012 Dec 22.
8
HMDB 3.0--The Human Metabolome Database in 2013.HMDB 3.0——2013 年的人类代谢物数据库。
Nucleic Acids Res. 2013 Jan;41(Database issue):D801-7. doi: 10.1093/nar/gks1065. Epub 2012 Nov 17.
9
CSF markers in amyotrophic lateral sclerosis.CSF 标志物在肌萎缩侧索硬化症中的应用。
J Neural Transm (Vienna). 2012 Jul;119(7):747-57. doi: 10.1007/s00702-012-0806-y. Epub 2012 May 4.
10
Inhibition of aggregation of amyloid β42 by arginine-containing small compounds.含精氨酸的小分子化合物对淀粉样β42聚集的抑制作用。
Biosci Biotechnol Biochem. 2012;76(4):762-6. doi: 10.1271/bbb.110879. Epub 2012 Apr 7.